Optimizing preoperative prophylaxis in patients with reported β-lactam allergy: a novel extension of antimicrobial

Alon Vaisman1, Janine McCready2, Sandy Hicks3

  • 1Division of Infectious Diseases, University Health Network, Toronto, Ontario M5G 2C4, Canada.

Abstract

Insights

Structured allergy histories can safely reduce alternative antibiotic use in patients with beta-lactam allergy undergoing surgery. This approach increased cefazolin use without adverse events, improving perioperative antibiotic prophylaxis.

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacy
  • Surgical Prophylaxis

Background:

  • Alternative second-line antibiotics in beta-lactam allergic patients are linked to adverse events.
  • Structured allergy histories, without skin testing, may decrease alternative prophylactic antibiotic use in surgery.

Purpose of the Study:

  • To evaluate the effect of structured allergy histories on patients with self-reported beta-lactam allergy (SRBA) undergoing elective surgery.

Main Methods:

  • Pharmacists conducted structured allergy histories, reviewed by infectious diseases physicians.
  • Patients with no history of type I-mediated or severe reactions were cleared for cefazolin prophylaxis.
  • Antibiotic prophylaxis orders were integrated into the computerized system for pre-incision administration.

Main Results:

  • 267 out of 485 patients (55.1%) with SRBA received cefazolin prophylaxis without adverse events.
  • Perioperative alternative antibiotic prophylaxis use decreased from 81.9% to 55.9% post-intervention.
  • The reduction in alternative antibiotic use correlated with monthly assessment frequency (P < 0.001).

Conclusions:

  • Structured allergy histories and prospective audit/feedback can increase cefazolin use for perioperative prophylaxis.
  • This strategy achieved increased cefazolin use without necessitating skin testing or diagnostic challenges.
  • No serious adverse events were observed, demonstrating the safety of this approach.

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
50
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.1K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
538
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
233
Antibiotic Selection00:57

Antibiotic Selection

Overview
61.0K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K